Yonglu Che

As a senior associate at Third Rock, Yonglu focuses on early-stage company creation, with a particular interest in immuno-oncology and cancer biology. He is passionate about translating cutting-edge science into transformative medicines and brings a unique perspective from both the lab and the clinic. Yonglu is a board-certified dermatologist specializing in cutaneous oncology and currently serves as an attending physician at Stanford’s Department of Dermatology. Before joining Third Rock, he conducted postdoctoral research in Howard Chang’s lab at Stanford, where he explored the role of B cells in response to checkpoint inhibitor therapy. His scientific work has spanned Ras-driven cancer biology, immune modulation, and targeted cancer therapeutics. Yonglu holds an MD and a PhD in Cancer Biology from Stanford, and undergraduate degrees in physics and biology from Yale.

Outside of work, Yonglu enjoys spending time with his wife and their two young children.